Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia

  • Aya M. Abdallah
  • , Hanafy Hafez
  • , Youssef Madney
  • , Sonia Ahmed
  • , Dina Yassin
  • , Sherine Salem
  • , Rodina Yousry
  • , Hisham Abdel-Azim
  • , Leslie Lehmann
  • , Alaa Elhaddad

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1024-1027
Number of pages4
JournalLeukemia and Lymphoma
Volume65
Issue number7
DOIs
StatePublished - 2024

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • BCR-ABL
  • Chronic myeloid leukemia
  • children
  • tyrosine kinase inhibitors
  • Prognosis
  • Tyrosine Kinase Inhibitors
  • Humans
  • Child, Preschool
  • Treatment Outcome
  • Male
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
  • Fusion Proteins, bcr-abl/genetics
  • Protein Kinase Inhibitors/therapeutic use
  • Adolescent
  • Female
  • Child

Cite this